Draper Associates

Activity from announced rounds

Activity in this selectionUnited States · Oct 23, 2026 · Jan 1, 2026

Draper Associates is a global venture firm investing in AI, robotics, blockchain, healthcare, biotechnology, aerospace and other emerging technologies.

Its blockchain thesis includes decentralised finance, tokenised assets and decentralised infrastructure. In healthcare, it focuses on technologies such as AI diagnostics, regenerative medicine and neurotechnology that can improve prevention and healthy lifespan.

The firm also backs automation and human-machine collaboration, alongside space technologies. Founders can submit a pitch directly through its website, which also provides an AI pitch-coaching tool.

Sources
Rounds participated in
12
Confirmed lead rounds
0
10 roles undisclosed
New companies
12
First participation on record · 0 follow-on
Funding in participating rounds
$419.5M
12 disclosed · full round size, not this investor’s share

By stage

Series A6
Seed4
Series B1
Undisclosed1

By primary sector

AI3
Biotech2
Defense tech2
Mobility2
Cybersecurity1
2 more
Hardware1
Space tech1

By country

United States12

Rounds

12 in this selection
Cloverleaf Bio

Cloverleaf Bio is developing engineered transfer RNA therapies that use a modified tRNA payload to inhibit cancer cells' RNA-modifying enzymes. Its lead program targets liver cancer and is advancing toward clinical testing; a second antibody-tRNA program for colorectal cancer remains preclinical.

$33MSeed
Participant
Poseidon Aerospace

Poseidon Aerospace is developing unmanned cargo aircraft for commercial freight and defense logistics. Its Egret short-takeoff-and-landing freighter and Heron seaplane are designed to move heavy loads between small, remote or water-based operating sites without an onboard pilot.

$11MSeed
Participant
Aurelius Systems

Develops AI-powered autonomous directed-energy systems to detect and neutralize drone threats

$40MSeries A
Role not disclosed
Venus Aerospace

Building next-generation propulsion systems for defense, space, and future high-speed flight

$91MSeries B
Role not disclosed
Syntax Bio

Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine

$14.4MSeries A+
Role not disclosed
Arpio

Automates disaster recovery and resilience testing for enterprises running complex cloud environments on AWS and Azure

$15MSeries A
Role not disclosed
Casimir

Casimir is developing semiconductor chips intended to supply power without conventional batteries.

$12MSeed
Role not disclosed
Scout AI

Develops AI foundation models that translate commander intent into coordinated unmanned system action

$100MSeries A
Role not disclosed
NODA AI

Builds AI orchestration software and autonomous agents for defense and intelligence operations

$25MSeries A
Role not disclosed
Ten63 Therapeutics

Develops AI-driven drug discovery platform for first- and best-in-class therapeutics

$45MStrategic
Role not disclosed
Natilus

Develops hyper-efficient blended-wing aircraft for commercial and defense aviation

$28MSeries A
Role not disclosed
Feltsense Holdings

Builds AI agents that function as autonomous founders to create and scale startups

$5.1MSeed
Role not disclosed